Back
Alnylam Pharmaceuticals Stock Predictions
Top investors are buying this "unlisted" stock
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.
Sell
41
ALNY
Alnylam Pharmaceuticals
Last Price:
$251.26
Seasonality Move:
25.91%
7 Day Trial
ALL ACCESS PASS
$
7
Spencer Rascoff co-founded Zillow, scaling it to a $16B valuation. But everyday investors couldn't invest until the IPO, missing early gains.
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.Alnylam Pharmaceuticals Stock Forecast
-
Over the next 52 weeks, Alnylam Pharmaceuticals has on average historically risen by 32.5% based on the past 20 years of stock performance.
-
Alnylam Pharmaceuticals has risen higher in 11 of those 20 years over the subsequent 52-week period, corresponding to a historical accuracy of 55%
-
Is Alnylam Pharmaceuticals Stock Undervalued?The current Alnylam Pharmaceuticals [ALNY] share price is $251.15. The Score for ALNY is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
-
ALNY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will Alnylam Pharmaceuticals Stock Go Up Next Year?
-
Over the next 52 weeks, Alnylam Pharmaceuticals has on average historically risen by 32.5% based on the past 20 years of stock performance.
Alnylam Pharmaceuticals Stock Rating
Sell
41
Alnylam Pharmaceuticals (ALNY)
is a Sell
Is Alnylam Pharmaceuticals overpriced?
-
Alnylam Pharmaceuticals has risen higher in 11 of those 20 years over the subsequent 52-week period, corresponding to a historical accuracy of 55%
Alnylam Pharmaceuticals Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
alnylam.com
52-Week Data
52-Week High:
304.39
52-Week Low:
144.73
Prediction Charts
Market Cap:
32.7B
Price in USD:
251.15
Volume:
656.4K
Beta:
1.18
Technical Analysis
SMA50:
251.22
SMA100:
252.79
SMA200:
259.09
52-Wk Change:
65.92%
Stock Predictions
-
Is Alnylam Pharmaceuticals stock public?Yes, Alnylam Pharmaceuticals is a publicly traded company.
-
What is the Alnylam Pharmaceuticals stock quote today?The Alnylam Pharmaceuticals stock price is 251.15 USD today.
-
How to buy Alnylam Pharmaceuticals stock online?You can buy Alnylam Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Apr-22 | 234.32 | 236.75 | 238.63 | 231.76 |
| Apr-23 | 243.92 | 241.97 | 248.59 | 240.01 |
| Apr-24 | 241.74 | 242.61 | 243.69 | 238.62 |
| Apr-25 | 241.90 | 251.56 | 253.25 | 240.00 |
| Apr-28 | 252.83 | 254.85 | 256.57 | 252.26 |
| Apr-29 | 256.14 | 257.19 | 260.54 | 253.83 |
| Apr-30 | 256.99 | 263.24 | 263.68 | 253.47 |
| May-1 | 257.14 | 255.13 | 265.91 | 247.71 |
| May-2 | 259.50 | 259.39 | 265.00 | 257.12 |
| May-5 | 259.09 | 273.55 | 273.97 | 257.23 |
| May-6 | 269.89 | 269.81 | 276.47 | 267.62 |
| May-7 | 270.00 | 276.55 | 277.85 | 269.72 |
| May-8 | 267.63 | 258.35 | 270.00 | 245.96 |
| May-9 | 259.92 | 251.15 | 260.00 | 250.35 |
Alnylam Pharmaceuticals Earnings
Alnylam Pharmaceuticals Earnings Report: Per Share Alnylam Pharmaceuticals Earnings Q1 Q2 Q3 and Q4 last year and next year.
Alnylam Pharmaceuticals Forecast Revenue Growth
Alnylam Pharmaceuticals Stock Analysis: Historical quarterly revenues per share for Alnylam Pharmaceuticals and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $1.15 per share, an increase next quarter of $1.52 per share, an increase this year of $1.31 per share, and an increase next year of $2.89 per share.
* Alnylam Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.